Oncology

Oncology covers companies developing therapies, diagnostics, and enabling technologies for cancer. On BioPharmSignal, this sector page groups businesses tied to solid tumors, hematologic malignancies, precision oncology, immuno-oncology, and other cancer-focused programs.

Why watch Oncology

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Oncology news

The latest feed items from companies currently grouped under Oncology.

1. 01
   2026-11-06 23:00 EST

   ANGOAngioDynamics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

   Source: AngioDynamics

2. 02
   2026-11-06 22:40 EST

   BIAFbioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization

   Source: bioAffinity Technologies, Inc.

3. 03
   2026-11-06 21:30 EST

   ORICORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

   Source: Oric Pharmaceuticals, Inc.

4. 04
   2026-11-06 21:01 EST

   NKTXNkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026

   Source: Nkarta

5. 05
   2026-11-06 21:01 EST

   INABIN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

   Source: IN8bio

6. 06
   2026-11-06 21:00 EST

   BMYBristol Myers Squibb Presents 56-Week Phase 3 Data in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) for Camzyos (mavacamten) at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions

   Source: BMYBristol-Myers Squibb Company

7. 07
   2026-11-06 17:00 EST

   IMCRImmunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma

   Source: Immunocore Holdings plc

8. 08
   2026-11-06 14:00 EST

   IMRXAtebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026

   Source: Immuneering

9. 09
   2026-11-06 14:00 EST

   CADLCandel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio

   Source: Candel Therapeutics

10. 10
    2026-11-06 14:00 EST

    IMCRImmunocore reports third quarter financial results and provides a business update

    Source: Immunocore Holdings plc

11. 11
    2026-11-06 13:00 EST

    ACRVAcrivon Expands into Immunology and Inflammation with Acquisition of Phase 2-Ready Differentiated, Oral JAK1 Inhibitor ACR-525, and PKCθ Inhibitor Preclinical Program from Aqilion AB

    Source: Acrivon Therapeutics

12. 12
    2026-11-06 13:00 EST

    TARAProtara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update

    Source: Protara Therapeutics

13. 13
    2026-11-06 12:30 EST

    KURAKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Kura Oncology

14. 14
    2026-11-06 10:50 EST

    FENCFennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026

    Source: Fennec Pharmaceuticals Inc.

15. 15
    2026-11-05 21:38 EST

    CRISCuris to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026

    Source: Curis Inc

16. 16
    2026-11-05 21:34 EST

    NKTXNkarta Reports Third Quarter 2026 Financial Results and Provides Business Update

    Source: Nkarta

17. 17
    2026-11-05 21:15 EST

    CTMXCytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update

    Source: CytomX Therapeutics, Inc.

18. 18
    2026-11-05 21:06 EST

    CADLCandel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    Source: Candel Therapeutics

19. 19
    2026-11-05 21:05 EST

    CRBUCaribou Biosciences Reports Third Quarter 2026 Financial Results

    Source: Caribou

20. 20
    2026-11-05 21:05 EST

    RNXTRenovoRx Reports Record Third Quarter 2026 Revenue Exceeding $1 Million

    Source: RenovoRx

Companies in Oncology

277 companies tagged with Oncology.

Frequently Asked Questions